REFERENCES
  1. Phillips SM, Padgett LS, Leisenring WM, et al. Survivors of childhood cancer in the United States: prevalence and burden of morbidity.Cancer Epidemiol Biomarkers Prev . 2016;24(4):653-663.
  2. Cheung AT, Li WHC, Ho LLK, Chan GCF, Chung JOK. Health support to pediatric cancer survivors and their families during the COVID-19 pandemic [published online ahead of print, 2020 Aug 9]. Pediatr Blood Cancer . 2020;e28441.
  3. Nekhlyudov L, Duijts S, Hudson SV, et al. Addressing the needs of cancer survivors during the COVID-19 pandemic. J Cancer Surviv.  2020;14(5):601-606.
  4. Fung M, Babik JM. COVID-19 in Immunocompromised Hosts: What We Know So Far [published online ahead of print, 2020 Jun 27]. Clin Infect Dis. 2020;ciaa863.
  5. Verbruggen LC, Wang Y, Armenian SH, et al. Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer . 2020;67(12):e28702.
  6. Perkins JL, Chen Y, Harris A, et al. Infections among long-term survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study. Cancer . 2014;120(16):2514-2521.
  7. Bryan A, Pepper G, Wener MH, et al. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho. J Clin Microbiol . 2020;58(8).
  8. Deeks JJ, Dinnes J, Takwoingi Y, et al. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev . 2020;6(6):CD013652.
  9. Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL. COVID-19 in Children With Cancer in New York City. JAMA Oncol.2020:e202028.
  10. NYC Department of Health. Coronavirus disease 2019 (COVID-19) Data. 2020; https://www1.nyc.gov/site/doh/covid/covid-19-data.page. Accessed September 18, 2020.
  11. de Rojas T, Pérez-Martínez A, Cela E, Baragaño M, Galán V, Mata C, Peretó A, Madero L. COVID-19 infection in children and adolescents with cancer in Madrid. Pediatr Blood Cancer. 2020 Jul;67(7):e28397.
  12. Fuereder T, Berghoff AS, Heller G, et al. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic. ESMO Open . 2020;5(5):e000889.
  13. Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA.  2020;323(22):2249–2251.